UB12:LSE:LSE-UBS MSCI Europe UCITS EUR A-dis (GBX)

ETF | Others |

Last Closing

USD 6937

Change

+80.50 (+1.17)%

Market Cap

N/A

Volume

1.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+0.38 (+0.14%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+0.41 (+0.28%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.39%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.05 (+0.30%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.48%)

USD 266.08B
0QZO:LSE 0QZO

+8.80 (+8.82%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.08 (+0.26%)

USD 218.91B
0QZ3:LSE Qualcomm Inc.

+2.23 (+1.38%)

USD 202.26B

ETFs Containing UB12:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.20% 30% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.20% 31% F 40% F
Trailing 12 Months  
Capital Gain 6.66% 36% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.66% 37% F 43% F
Trailing 5 Years  
Capital Gain 21.12% 48% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.12% 48% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 7.15% 55% F 60% D-
Dividend Return 7.15% 54% F 59% D-
Total Return 0.00% 9% A- 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 9.76% 68% D+ 82% B
Risk Adjusted Return 73.20% 76% C+ 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.